Publications by authors named "Gabriela A Burle-Caldas"

Article Synopsis
  • * Inositol phosphorylceramide (IPC) plays a key role in leishmania species, with IPC synthase (IPCS) being a critical enzyme; clemastine fumarate has emerged as a potential IPCS inhibitor and an anti-leishmanial agent.
  • * Research reveals that while clemastine fumarate inhibits IPCS and alters metabolic pathways, its main action may involve different targets, suggesting further investigation is needed for effective treatment strategies.
View Article and Find Full Text PDF

Sphingolipids (SLs) are essential components of all eukaryotic cellular membranes. In fungi, plants and many protozoa, the primary SL is inositol-phosphorylceramide (IPC). Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD), a chronic illness for which no vaccines or effective treatments are available.

View Article and Find Full Text PDF

With current drug treatments failing due to toxicity, low efficacy and resistance; leishmaniasis is a major global health challenge that desperately needs new validated drug targets. Inspired by activity of the natural chalcone 2',6'-dihydroxy-4'-methoxychalcone (DMC), the nitro-analogue, 3-nitro-2',4',6'- trimethoxychalcone (NAT22, 1c) was identified as potent broad spectrum antileishmanial drug lead. Structural modification provided an alkyne containing chemical probe that labelled a protein within the parasite that was confirmed as cytosolic tryparedoxin peroxidase (cTXNPx).

View Article and Find Full Text PDF

CRISPR/Cas9 technology has been used to edit genomes in a variety of organisms. Using the GP72 gene as a target sequence, we tested two distinct approaches to generate Trypanosoma cruzi knockout mutants using the Cas9 nuclease and in vitro transcribed single guide RNA. Highly efficient rates of disruption of GP72 were achieved either by transfecting parasites stably expressing Streptococcus pyogenes Cas9 with single guide RNA or by transfecting wild type parasites with recombinant Staphylococcus aureus Cas9 previously associated with single guide RNA.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the immune response to ribosomal protein L7a from the Chagas disease-causing agent, focusing on its amino acid repeats.
  • Mice vaccinated with the full-length protein showed strong antibody and immune activity, while those given truncated versions exhibited low responses and were less protected against infection.
  • Importantly, immunization with the repeat-only version led to increased disease severity and reduced antibody production, suggesting that the repeat domain acts as an immunosuppressive factor.
View Article and Find Full Text PDF

Gene function studies in Trypanosoma cruzi, the protozoan parasite that causes Chagas disease, have been hindered by the lack of efficient genetic manipulation protocols. In most organisms, insertion and deletion of DNA fragments in the genome are dependent on the generation of double-stranded DNA break (DSB) and repair. By inducing a site-specific DSB, zinc finger nucleases (ZFNs) have proven to be useful to enhance gene editing in many cell types.

View Article and Find Full Text PDF

In trypanosomatids, transcription is polycistronic and gene expression control occurs mainly at the post-transcriptional level. To investigate the role of sequences present in the 3'UTR of stage-specific mRNAs of Trypanosoma cruzi, we generated a new vector, named pTcDUALuc, containing the firefly and Renilla luciferase reporter genes. To test this vector, sequences derived from the 3'UTR plus intergenic regions of the alpha tubulin gene, which is up-regulated in epimastigotes, and amastin, which is up-regulated in amastigotes, were inserted downstream from the firefly reporter gene and luciferase activity was compared in transient and stable transfected parasites.

View Article and Find Full Text PDF